Consensus Instil Bio, Inc.

Equities

TIL

US45783C2008

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-24 pm EDT			5-day change	1st Jan Change
11.04 ^USD	-1.82%		-4.04%	+44.82%

May. 13	Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating	MT
May. 10	Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Instil Bio, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e9f6aacfc28e28.jX-FjAyhs9BleWiRL7Z2Iz7pKmfIi0upXNQT1Ructic.1UbG-X31gIkuGz-nQN46dk25HTCmwSLnP59dkG39wR7IMOPqQ9jB4xY3Hw~c6e7eb0d81ae0ea59b664ddcb158207d

Analyst Recommendations on Instil Bio, Inc.

Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating	May. 13	MT
Jefferies Downgrades Instil Bio to Hold From Buy	Apr. 12	MT
HC Wainwright Initiates Instil Bio With Buy Rating, $2 Price Target	23-06-29	MT
Truist Securities Reinstates Instil Bio at Hold	23-04-05	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $2 From $6, Keeps Equalweight Rating	22-12-12	MT
Baird Lowers Price Target on Instil Bio to $14 From $24, Maintains Outperform Rating	22-11-17	MT
Morgan Stanley Adjusts Instil Bio Price Target to $6 From $8, Maintains Equal Weight Rating	22-11-01	MT
Baird Adjusts Instil Bio's Price Target to $24 From $31, Keeps Outperform Rating	22-11-01	MT
Cowen Downgrades Instil Bio to Market Perform From Outperform	22-11-01	MT
Baird Lowers Price Target on Instil Bio to $31 From $34, Maintains Outperform Rating	22-09-06	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $8 From $9, Maintains Equalweight Rating	22-08-24	MT
Truist Securities Adjusts Instil Bio's Price Target to $16 from $25, Maintains Buy Rating	22-08-23	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $9 From $14, Keeps Equalweight Rating	22-06-06	MT
Instil Bio Shares Drop 35% After FDA IND Clearance and Truist Price Target Cut	22-05-27	DJ
Morgan Stanley Adjusts Instil Bio Price Target to $14 From $15, Maintains Equal Weight Rating	22-05-24	MT
INSTIL BIO : Baird Starts Instil Bio at Outperform With $34 Price Target	21-08-13	MT
INSTIL BIO : Morgan Stanley Adjusts Instil Bio's Price Target to $23 From $24, Keeps Equal-Weight Rating	21-05-26	MT
INSTIL BIO : Jefferies Starts Instil Bio at Buy with $31 Price Target	21-04-13	MT
INSTIL BIO : Cowen Starts Instil Bio at Outperform	21-04-13	MT
INSTIL BIO : Morgan Stanley Initiates Coverage on Instil Bio With Equal-Weight Rating, $24 Price Target	21-04-13	MT
INSTIL BIO : Truist Securities Starts Instil Bio at Buy With $32 Price Target	21-04-13	MT